国外医院处方集新药的遴选过程与标准介绍  

Introduction on selecting process and criteria for new drugs in hospital formulary in foreign countries

作　　者：张钰宣[1] 梅丹[1] 

机构地区：[1]中国医学科学院北京协和医院药剂科,北京100730

出　　处：《中国医院药学杂志》2015年第10期865-868,共4页Chinese Journal of Hospital Pharmacy

基　　金：国家临床重点专科建设项目

摘　　要：目的:调查国内外处方集新药的遴选过程及影响因素。方法:通过阅读国内外文献对所报道的药事管理与药物治疗学委员会的组成和职能以及处方集新药的遴选过程和影响因素等内容进行分析。结果:处方集新药的遴选主要由药事管理与药物治疗学委员会负责组织进行,药师负责对申请新药进行评估并交由药事会讨论。药品的有效性和安全性是首要考虑因素,经济学因素和操作性方面的因素次之。结论:新药上会前的药品评估过程是药品遴选的关键环节,药品的安全性和有效性是影响药品能否过会的关键因素。OBJECTIVE To explore process and influencing factors of new medication selection. METHODS Literatures were reviewed to find out functions of Pharmacy Therapeutics Committee （PTC） and how it worked to screen formulary of hos- pitals. RESULTS Pharmacists were responsible for assessing new medications, which would be discussed by the PTC. Effica- cy and safety were primary considerations, followed by operational aspects and economics. CONCLUSION Assessment is im- portant for selection of medications, and efficacy and safety are the key factors.

关 键 词：处方集 新药 

分 类 号：R952[医药卫生—药学]